527
Participants
Start Date
October 23, 2020
Primary Completion Date
April 22, 2022
Study Completion Date
April 22, 2022
Lenzilumab
Lenzilumab is a first-in-class recombinant monoclonal antibody targeting soluble human GM-CSF, with potential immunomodulating activity, high binding affinity in the pM range, and 94% specificity to the human germline, which reduces immunogenicity.
Placebo
Placebo for lenzilumab is commercially sourced 0.9% sodium chloride.
Remdesivir
Remdesivir is a single diastereomer monophosphoramidate prodrug designed for the intracellular delivery of a modified adenine nucleoside analog GS-441524.
Stony Brook Medicine - Stony Brook University Hospital, Stony Brook
Nuvance Health - Vassar Brothers Medical Center, Poughkeepsie
Seoul National University Bundang Hospital - Division of Infectious Diseases, Bundang-gu Seongnam-si
The State University of New York - University at Buffalo - Department of Medicine, Buffalo
Penn State Health Milton S. Hershey Medical Center - Division of Infectious Diseases, Hershey
Doylestown Hospital, Doylestown
West Virginia University - Infectious Diseases Clinic, Morgantown
Wake Forest Baptist Health - Infectious Diseases, Winston-Salem
Atrium Health ID Consultants & Infusion Care Specialists, Charlotte
Grady Memorial Hospital, Atlanta
Mayo Clinic Florida, Jacksonville
University of Florida Health - Shands Hospital - Division of Infectious Diseases and Global Medicine, Gainesville
University of Alabama at Birmingham School of Medicine - Infectious Disease, Birmingham
Norton Healthcare, Louisville
University of Louisville - Division of Infectious Diseases, Louisville
University of Toledo Medical Center - Ruppert Clinic, Toledo
Hennepin Healthcare Research Institute, Minneapolis
Monument Health - Clinical Research, Rapid City
Northwestern Medicine - Central DuPage Hospital - Infectious Disease, Winfield
Cook County Health and Hospitals System - Ruth M Rothstein CORE Center, Chicago
Rush University Medical Center, Chicago
Great Lakes Clinical Trials, Chicago
Carle Foundation Hospital, Urbana
University of Nebraska Medical Center - Infectious Diseases, Omaha
Baylor Scott & White Health - Baylor University Medical Center - North Texas Infectious Disease Consultants, Dallas
Methodist Hospital - Houston, Houston
Baptist Hospitals of Southeast Texas Site, Beaumont
Hendrick Health - Hendrick Medical Center, Abilene
St. Anthony Hospital North Health Campus, Westminster
Penrose Hospital - Emergency Medicine, Colorado Springs
St. Francis Medical Center, Colorado Springs
University of Utah - Infectious Diseases, Salt Lake City
Hoag Hospital Newport Beach, Newport Beach
UCSF Fresno Center for Medical Education and Research - Clinical Research Center, Fresno
St. Charles Health System - St. Charles Bend Hospital, Bend
The University of Arizona - Banner University Medical Center Tucson Campus - Tucson, Tucson
University of Arkansas for Medical Sciences, Little Rock
Kern Medical Center, Bakersfield
University of Southern California - Infectious Diseases, Los Angeles
Stanford University - Stanford Hospital and Clinics - Pediatrics - Infectious Diseases, Stanford
St. Anthony Hospital, Lakewood
Nuvance Health Danbury Hospital - Infectious Disease, Danbury
Yale School of Medicine - The Anlyan Center for Medical Research & Education - Immunobiology, New Haven
Nuvance Health - Norwalk Hospital - Asthma Pulmonary and Critical Care Medicine, Norwalk
The Hope Clinic of Emory University, Decatur
Brigham and Women's Hospital - Infectious Diseases, Boston
Boston Medical Center - Center for Infectious Diseases - Shapiro Center, Boston
William Beaumont Hospital - Royal Oak Campus - Infectious Disease, Royal Oak
Mayo Clinic, Rochester - Infectious Diseases, Rochester
Englewood Hospital, Englewood
Mount Sinai School of Medicine - Medicine - Infectious Diseases, New York
Jacobi Medical Center, The Bronx
Montefiore Medical Center - Infectious Diseases, The Bronx
Kent County Memorial Hospital, Warwick
Seoul National University Hospital, Seoul
National Institute of Allergy and Infectious Diseases (NIAID)
NIH